SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-138915
Filing Date
2023-05-09
Accepted
2023-05-09 07:38:03
Documents
13
Period of Report
2023-05-09
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d420874d8k.htm   iXBRL 8-K 28717
2 EX-99.1 d420874dex991.htm EX-99.1 9863
  Complete submission text file 0001193125-23-138915.txt   166052

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA adpt-20230509.xsd EX-101.SCH 2874
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE adpt-20230509_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adpt-20230509_pre.xml EX-101.PRE 11277
7 EXTRACTED XBRL INSTANCE DOCUMENT d420874d8k_htm.xml XML 3413
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38957 | Film No.: 23900011
SIC: 2836 Biological Products, (No Diagnostic Substances)